Cargando…
Linezolid-Induced Pure Red Cell Aplasia: A Case Report
Linezolid (LZD) has been widely used for treating the infections of multidrug-resistant gram-positive organisms. As we know, anemias induced by Linezolid (LZD) are common. However, LZD-induced pure red cell aplasia (PRCA) is very rare. In this paper, we report on a 68-year-old woman with intravascul...
Autores principales: | Yang, Xiao-Yan, Chen, Lin, Gu, Ji-Na, Zeng, Cheng-Jun, Pan, Dan-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309292/ https://www.ncbi.nlm.nih.gov/pubmed/35899083 http://dx.doi.org/10.2147/IDR.S362358 |
Ejemplares similares
-
Linezolid-induced pure red cell aplasia: a case report and literature review
por: Luo, Zhuanbo, et al.
Publicado: (2018) -
Emtricitabine-induced pure red cell aplasia
por: Manickchund, Nithendra, et al.
Publicado: (2019) -
Myelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
por: Kim, Hyoung Doo, et al.
Publicado: (2004) -
Zidovudine-induced reversible pure red cell aplasia
por: Balakrishnan, Anuja, et al.
Publicado: (2010) -
TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib
por: Poudyal, Bishesh Sharma, et al.
Publicado: (2016)